文献速递急性肾损伤血液净化与透析

南美人群需透析急性肾损伤的表型与死亡率关联

Phenotypes of Dialysis-Requiring Acute Kidney Injury and Associations with Mortality in a South American Population.
PubMed 文献 · Clin J Am Soc Nephrol · 2024-09-12

该研究分析巴西里约热内卢170家医疗机构2002–2012年间17,158例需透析急性肾损伤患者,采用潜在类别分析识别出四种临床表型,各表型临床特征与死亡率不同,提示需按年龄和病因制定管理策略。

要点

  • 潜在类别分析识别出四种需透析AKI表型,死亡率从39.5%到82.8%不等。
  • 感染是最常见病因(44.2%),其中社区获得性肺炎占23.8%。
  • 不同表型在合并症负担、器官支持需求和恢复率上存在显著差异。

核心结论

  • 需透析急性肾损伤存在四种 distinct 临床表型,各表型死亡风险和恢复情况不同。
  • 病因谱随年龄变化,提示需制定年龄特异性的AKI管理策略。

研究设计与样本

  • 多中心回顾性队列研究,纳入巴西里约热内卢170家医疗机构2002–2012年间17,158例需透析AKI患者。
  • 使用生存曲线和混合效应Cox回归进行生存估计,采用潜在类别分析基于临床特征和结局对患者分类。

主要发现

  • 患者中位年龄75岁(四分位距59–83)。
  • 感染为最常见病因(44.2%),其中心社区获得性肺炎占23.8%;心血管问题中缺血性心脏病占9.0%,急性心力衰竭占8.1%。
  • 类别1患者较年轻(中位年龄66岁),以男性为主,ICU入住率较低,社区获得性AKI比例较高(60.8%),死亡率最低(39.5%),恢复率最高。
  • 类别2死亡率居中(67.4%),合并症负担最高(平均Charlson评分3.39)。
  • 类别3和4死亡率最高(分别为82.8%和78.6%),需要更多机械通气和血管加压药;类别3脓毒症患病率高(92.7%)且合并症较少,类别4慢性心脏病(76.3%)和灌注因素(79.4%)比例高。

临床怎么用

  • 临床可依据潜在类别分析识别的表型(如年龄、合并症、病因、器官支持需求)对需透析AKI患者进行风险分层。
  • 针对不同表型(如高脓毒症风险或高心血管合并症)采取个体化监测和治疗策略。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

KEY POINTS: Comprehensive analysis of 17,158 patients with dialysis-requiring AKI in Brazil, uncovering intricate etiological patterns and outcomes across all age groups. Detailed latent class analysis reveals four distinct phenotypes for patients with dialysis-requiring AKI, each with unique clinical characteristics and mortality risks. The study underscores the necessity of age-specific AKI management strategies, informed by diverse etiologies and survival outcomes across the lifespan. BACKGROUND: AKI is a complex syndrome typically classified into strict categories. Alternatively, it may be more accurate to consider it as an intermediate event between an initiating cause and its outcome. Therefore, we investigated the burden of clinical scenarios associated with dialysis-requiring AKI using latent class analysis (LCA) and examined the etiological spectrum and clinical phenotypes across different life stages. METHODS: We analyzed 17,158 patients with dialysis-requiring AKI from 170 medical facilities in Rio de Janeiro, Brazil (2002–2012). Using survival curves and mixed-effects Cox regression for survival estimation, LCA classified patients on the basis of clinical characteristics and outcomes, focusing on etiological variation over the human lifespan. RESULTS: The median age was 75 years (interquartile range, 59–83). Infections were the most common cause (44.2%), particularly community-acquired pneumonia (23.8%). Cardiovascular issues, especially ischemic heart disease (9.0%) and acute heart failure (8.1%), were also significant. LCA identified four distinct patient classes with varying clinical and outcome profiles. Class 1 patients were younger (median age, 66 years), predominantly male, with lower intensive care unit admission rates and higher rates of community-acquired AKI (60.8%). They had the lowest mortality (39.5%) and highest recovery rates. Class 2 had intermediate mortality (67.4%) and the highest comorbidity burden (mean Charlson score, 3.39). Classes 3 and 4 had the highest mortality (82.8% and 78.6%, respectively), requiring more mechanical ventilation and vasopressor use. Class 3 had a high prevalence of sepsis (92.7%) with lower comorbidities while class 4 had high chronic heart disease (76.3%) and perfusion factors (79.4%). Despite high mortality, class 3 patients recovered better than class 2 and 4 patients. Survival analyses revealed diverse outcomes across etiological groups, with liver-related conditions being the most severe. CONCLUSIONS: This study highlights the complexity of AKI and utility of LCA in revealing its clinical heterogeneity. It underscores distinct etiological trends across ages, suggesting future research should integrate clinical profiles with advanced diagnostics to understand AKI's clinical and molecular phenotypes throughout life.

来源:Clin J Am Soc Nephrol,查看原文。版权归原作者所有。

引用

  1. Gomes CLR, Cleto-Yamane TL, da Silva Fucuta P, et al. Phenotypes of Dialysis-Requiring Acute Kidney Injury and Associations with Mortality in a South American Population. Clin J Am Soc Nephrol. 2024. PMID: 39264733. doi:10.2215/CJN.0000000000000530

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。